Human Interferon Gamma + Granzyme B ELISPOT Set
Be the first to review this product! Submit a review
|
(0 Publication)
Human Interferon Gamma + Granzyme B ELISPOT Set is a ELISPOT set for the sensitive detection of Human Interferon Gamma + Granzyme B production in a single cell suspension.
View Alternative Names
Interferon gamma, IFN-gamma, Immune interferon, IFNG, CGL1, CSPB, CTLA1, GRB, GZMB, Granzyme B, C11, CTLA-1, Cathepsin G-like 1, Cytotoxic T-lymphocyte proteinase 2, Fragmentin-2, Granzyme-2, Human lymphocyte protein, SECT, T-cell serine protease 1-3E, CTSGL1, Lymphocyte protease, HLP
Reactivity data
Product details
The ELISPOT assay is designed to enumerate cytokine producing cells in a single cell suspension. This method has the advantage of requiring a minimum of in-vitro manipulations allowing cytokine production analysis as close as possible to in-vivo conditions in a highly specific way. This technique is designed to determine the frequency of cytokine producing cells under a given stimulation, and the follow-up of such frequency during a treatment and/or a pathological state. ELISPOT assay constitutes an ideal tool in the TH1 / TH2 response, vaccine development, viral infection monitoring and treatment, oncology, infectious diseases, autoimmune diseases and transplantation.
This ELISPOT assay is based on sandwich immuno-enzyme technology. Cell secreted cytokines or soluble molecules are captured by coated antibodies avoiding diffusion in supernatant, protease degradation or binding on soluble membrane receptors. After cell removal, the captured cytokines are revealed by tracer antibodies and appropriate conjugates.
The dual colour ELISPOT allows you to monitor the production of two cytokines simultaneously in the same well.
Principle of the Method
After cell stimulation, locally produced cytokines are captured by IFN gamma and Granzyme B specific monoclonal antibodies. After cell lysis, trapped cytokine molecules are revealed by a secondary anti-IFN gamma FITC conjugated antibody and a biotinylated anti-Granzyme B antibody. Those are in turn recognised by anti-FITC HRP and streptavidin-AP conjugates. PVDF-bottomed-well plates are then incubated first with AEC substrate buffer, washed and subsequently incubated with BCIP/NBT. Coloured red/brownish spots indicate IFN gamma production while Granzyme B is revealed by blue/purple spots.
What's included?
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
IFN-γ activates macrophages enhances antigen presentation and orchestrates the Th1 immune response by inducing the expression of MHC class II molecules. It is not part of any protein complex. Granzyme B on the other hand induces apoptosis in target cells by cleaving caspases and various cellular substrates. It operates as part of the cytotoxic granule complex alongside perforin which forms pores in target cell membranes to facilitate Granzyme B entry.
Pathways
IFN-γ plays an important role in the JAK-STAT signaling pathway which is fundamental for its action in immune modulation. Through JAK-STAT it works closely with STAT1 a specific transcription factor. Granzyme B is involved in the induction of apoptosis through the mitochondrial pathway where its activity intersects with Bid a pro-apoptotic Bcl-2 family member. These proteins contribute significantly to the regulation and execution of immune responses.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
- Download websiteProtocolBooklet|en
Target data
Additional targets
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com